Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis.
Saved in:
| Title: | Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis. |
|---|---|
| Authors: | Deimel LP; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra ACT 2601, Australia., Li Z; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra ACT 2601, Australia., Ranasinghe C; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra ACT 2601, Australia. |
| Source: | Journal of clinical and translational research [J Clin Transl Res] 2021 Feb 25; Vol. 7 (1), pp. 116-120. Date of Electronic Publication: 2021 Feb 25 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AccScience Publishing Country of Publication: Singapore NLM ID: 101667205 Publication Model: eCollection Cited Medium: Internet ISSN: 2424-810X (Electronic) Linking ISSN: 23826533 NLM ISO Abbreviation: J Clin Transl Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2424-810X |
|---|
